Welcome to our dedicated page for Global Medical news (Ticker: GMRE), a resource for investors and traders seeking the latest updates and insights on Global Medical stock.
Global Medical REIT Inc. (GMRE) provides essential healthcare infrastructure through its portfolio of specialized medical facilities. This news hub offers investors and industry professionals centralized access to official announcements and market developments.
Track critical updates including property acquisitions, lease agreements with healthcare providers, and financial performance reports. Our curated collection ensures timely access to strategic partnerships, portfolio expansions, and operational milestones that shape this healthcare REIT's trajectory.
All content undergoes strict verification to maintain accuracy and relevance. Users benefit from comprehensive coverage of GMRE's unique position in medical real estate, including its focus on triple-net lease structures and secondary market specialization.
Bookmark this page for efficient monitoring of GMRE's evolving role in healthcare property markets. Combine regular visits with professional financial analysis when making informed decisions about this niche REIT investment.
Global Medical REIT (NYSE: GMRE) reported strong third quarter 2021 results with a net income of $3.7 million, or $0.06 per diluted share, recovering from a net loss of $(10.3) million in the previous year. Revenue surged by 19.5% to $30.0 million, driven by significant acquisitions totaling $163 million year-to-date. Funds from Operations (FFO) rose to $0.23 per share. The portfolio remains robust with 99% occupancy and favorable rent coverage of 4.6 times. Management plans further acquisitions, maintaining growth momentum.
Global Medical REIT Inc. (NYSE: GMRE) announced its plans to release third quarter 2021 financial results on November 3, 2021, after market close. A subsequent conference call will occur on November 4, 2021, at 9:00 a.m. Eastern Time. The call will be hosted by CEO Jeffrey Busch and his team. Investors can access the call via live webcast on the company's website. A replay will be available from 12:00 p.m. ET on November 4 until midnight ET on November 18.
Global Medical REIT (NYSE: GMRE) has declared its 2021 third quarter dividends. The common cash dividend is set at $0.205 per share, payable on October 8, 2021, to stockholders of record as of September 24, 2021. Additionally, a quarterly cash dividend of $0.46875 per share on its Series A Preferred Stock will be paid on November 1, 2021, for Series A Preferred shareholders of record as of October 15, 2021.
Global Medical REIT (NYSE: GMRE) reported strong financial results for Q2 2021, with net income of $2.6 million ($0.04 per diluted share), up from $0.2 million last year. Total revenue increased by 28.1% year-over-year to $28.3 million, driven by significant acquisition activity. Funds from Operations (FFO) rose to $0.22 per share, while Adjusted Funds from Operations (AFFO) reached $0.23 per share. The company completed seven acquisitions for $71 million, maintaining a 99% portfolio occupancy rate. GMRE also reduced leverage from 52% to 41% through equity offerings totaling $201 million.
Global Medical REIT (NYSE: GMRE) announced plans to release its second quarter 2021 financial results post-market on August 3, 2021. A conference call will follow on August 4, 2021, at 9:00 a.m. ET, featuring CEO Jeffrey Busch, CFO Robert Kiernan, and CIO Alfonzo Leon. The call can be accessed via webcast on the company’s investor site, with dial-in options available for those unable to use the webcast. A replay will be accessible from 12:00 p.m. ET on August 4 until midnight ET on August 18, 2021.
Global Medical REIT (NYSE: GMRE) has declared its second quarter 2021 dividends. The common cash dividend is set at $0.205 per share, payable on July 8, 2021 to shareholders on record as of June 24, 2021. Additionally, a quarterly cash dividend of $0.46875 per share will be paid on the Series A Preferred Stock on August 2, 2021 for stockholders of record by July 15, 2021. This reflects GMRE's continued commitment to returning value to its investors.
Global Medical REIT Inc. (GMRE) reports Q1 2021 results with a net income of $1.8 million ($0.03/share), an increase from $1.3 million from last year. Total revenue rose 26.3% to $27.3 million, driven by nine acquisitions totaling $101 million at a 7.4% cap rate. Funds from Operations (FFO) improved to $0.23/share, while Adjusted Funds from Operations (AFFO) rose to $0.24/share. The portfolio remains robust with 99.1% occupancy. The company reduced leverage from 51.7% to 41.1% following $150 million in equity offerings and an improved credit facility, enhancing financial stability.
Global Medical REIT (NYSE: GMRE) has successfully amended its credit facility, increasing its borrowing capacity by $150 million to a total of $750 million. The facility now features reduced borrowing costs, conversion to an unsecured facility, and extended maturity dates for both the revolver and term loan components. The new structure consists of a $400 million revolver, a $350 million term loan, and a $500 million accordion feature. CEO Jeffrey M. Busch highlighted the enhanced financial flexibility and improved credit profile this agreement provides, crucial for the company's growth strategy.
Global Medical REIT (NYSE: GMRE) plans to announce its Q1 2021 financial results on May 5, 2021, after market close. A conference call is scheduled for May 6, 2021, at 9:00 a.m. ET, featuring CEO Jeffrey Busch, CFO Robert Kiernan, and CIO Alfonzo Leon. Interested parties can join via a live webcast on the company's investor website or call in using designated U.S. and international numbers. A replay of the call will be available from 12:00 p.m. ET on May 6 until midnight ET on May 20, 2021.
Global Medical REIT Inc. (NYSE:GMRE) has announced a public offering of 7,500,000 shares of common stock priced at $13.30 per share, aiming to raise gross proceeds of $99,750,000. The funds will be utilized for repaying debt, funding acquisitions, and general corporate purposes. An additional 1,125,000 shares may be purchased underwriters within 30 days. The offering is set to close on March 18, 2021, pending customary conditions. The shares will be issued under a shelf registration statement effective since June 17, 2020.
